Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 15 June 2009, doi:10.1136/bmj.b1460
Cite this as: BMJ 2009;338:b1460
Increased longevity as a result of HAART raises new questions about the best treatment
| The first 150 words of the full text of this article appear below. |
The median age of people living with HIV in the developed world is increasing because of improved longevity from highly active antiretroviral therapy (HAART) and an increase in new HIV infections in older people.1 The prevalence of HIV in older people will continue to increase over the next decade, and around 50% of people living with HIV will be older than 50 by 2015.2 Although 50 years is not a common threshold for advanced age, early in the HIV epidemic the Centres for Disease Control and Infection identified HIV infected patients aged 50 or more as a separate group because the mean age of infected people was then much lower than 50.
In the early days of the HIV epidemic older patients had higher morbidity, higher mortality, and a shorter AIDS free survival than younger people with HIV. Some of this disparity was caused by late diagnosis in older patients
Kelly A Gebo, associate professor of medicine, epidemiology
1 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
kgebo@jhmi.edu
Read all Rapid Responses